Resmed is a medical company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker RMD on the NYSE exchange.
Resmed stock last closed at $183.42, down 0.2% from the previous day, and has decreased 19.06% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.06 percentage points. Resmed stock is currently +38.7% from its 52-week low of $132.24, and -24.68% from its 52-week high of $243.52.
As of Apr 25, 2024, there are 147.09M shares of RMD outstanding. The market cap of RMD is $26.98B. In the last 24 hours, 1.11M RMD shares were traded.
How to Buy Resmed Stock
Wondering how to invest in Resmed stock? Here's how.
Decide where to buy Resmed stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you choose where to buy Resmed stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Choose your method of payment and add your details.
Analyze Resmed stock: The Resmed ticker symbol is RMD. Is Resmed stock a good investment? Should you buy shares of RMD? How do RMD's underlying business fundamentals look? Do top analysts think Resmed is a good buy? Why has RMD's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if RMD is a good stock to buy).
Execute your RMD buy order: Decide if you will purchase RMD shares at the current market price or use a limit order to buy RMD stock at a particular price.
Get updates on your RMD investment: Create a watchlist to watch your position in Resmed stock.
Step 1: Decide where to buy Resmed stock
You need a brokerage account in order to access the NYSE market and buy RMD shares.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Technology to Financial Services, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal details so you can invest in RMD stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Resmed stock
Once you have decided on the best place to buy Resmed stock, it's important to research their stock prior to investing, so you truly understand the risk and opportunity.
Resmed Numbers
RMD Price
$183.42
1w %
3.27%
1y %
-19.06%
5y %
79.38%
P/E
30.27x
P/B
6.02x
P/S
5.99x
PEG
1.76x
Revenue
$4.50B
Earnings
$890.39M
Fore. Rev. Growth
5.11%
Fore. Earn. Growth
19.13%
Market Cap
$26.98B
Next Earnings
N/A
Next Dividend
N/A
RMD Zen Score
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis in less time.
You can see all of the due diligence checks on RMD's stock page.
How is RMD stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge RMD's true value.
Using relative valuations measures:
RMD may be undervalued based on its P/E ratio of 30.27x, relative to Medical Instruments & Supplies industry P/E ratio of 47.92x
RMD may be overvalued based on its P/B ratio of 6.02x, relative to Medical Instruments & Supplies industry P/B ratio of 3.49x
RMD may be overvalued based on its PEG ratio of 1.76x
You can access additional valuation analysis on RMD's stock here.
RMD Financial Health Summary
Positive Health Checks:
There are more short-term assets than short-term liabilities on the RMD balance sheet.
RMD earnings of $1.16B is not sufficient to cover its interest payments.
There are more short-term assets than long-term liabilities on the RMD balance sheet.
RMD's operating cash flow of $1.08B allows it to safely service it's debt of $1.39B.
Total RMD debt is lower than 5 years ago, relative to shareholder equity.
Negative Health Checks:
RMD has a relatively high debt to equity ratio of 0.54.
RMD profit margin has gone down from 21.5% to 19.8% in the past year.
Is it a good time to buy Resmed stock, according to analysts?
Out of 8 Wall Street analysts who track RMD, the consensus analyst rating on Resmed is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest RMD Analyst Forecasts
Craig Wong-Pan, a top 47% analyst from RBC Capital maintains RMD with a hold rating and raises their RMD price target from $181.00 to $182.00, on Jan 25, 2024.
David Low, a top 45% analyst from JP Morgan maintains RMD with a strong buy rating and raises their RMD price target from $160.00 to $195.00, on Jan 9, 2024.
Sean Laaman, a bottom 50% analyst from Morgan Stanley upgrades RMD to a strong buy rating and announces their RMD price target of $169.00, on Oct 27, 2023.
Last year, RMD earnings were $890.39M. During the last 5 year, RMD's earnings have gone up by 13.98% per year. This was slower than the Medical Instruments & Supplies industry average of 16.78%.
Last year, RMD revenue was $4.50B. In the last 5 year, RMD's revenue has grown by 12.91% per year. This was faster than the Medical Instruments & Supplies industry average of 9.46%.
Resmed pays a dividend of 1.02%, compared to the Medical Instruments & Supplies industry's average dividend yield of 1.34%. If you owned $1,000 worth of RMD stock, you would have received $10.25 last year.
Resmed dividend payments have consistently grown over the past decade and have remained stable.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your RMD buy order
You have two main options:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are mostly fine.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular price limit, use a limit order.
Press the Open Trade button and your broker will execute your order.
If you want more info about investing in stocks on eToro, watch the helpful video below:
As of Apr 25, 2024, it costs $183.42 to buy one share of Resmed stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.545 shares of RMD.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.